Generate a tailored SOP for Dr. Adil Mardinoglu. Improve your application with a focused, well-structured draft.
Dr. Adil Mardinoglu works at the Science Life Laboratory (SciLifeLab) at KTH Royal Institute of Technology in Sweden as an expert in Systems Biology and Artificial Intelligence. He leads a 15-strong research team focused on developing novel treatment strategies for metabolic neurodegenerative diseases and cancers, integrating multiomics, systems biology, AI, and experimental biology into drug development. A key contributor to the Swedish Human Protein Atlas program, Dr. Mardinoglu has aided in the construction of a comprehensive human tissue, subcellular, and pathology atlas, which has been instrumental in developing the cell atlas for the international Human Cell Atlas initiative. His scholarly output includes over 290 research and review articles, published in prestigious journals such as Science, Nature, Biotechnology, Cell Metabolism, Nature Metabolism, Nature Communications, PNAS, Cell Reports, and Molecular Systems Biology. Additionally, he is a co-founder of several biotech companies, including SZA Longevity, ScandiBio Therapeutics, ScandiEdge Therapeutics, and Trustlife Therapeutics, contributing significantly to the biotech sector.
KTH Royal Institute of Technology • Stockholm, Sweden
Leading a research team in systems biology and artificial intelligence.
Master's programs are organized under Schools; departments listed are units within these schools (e.g., EECS, ABE, CBH, ITM, SCI).